These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9477619)

  • 1. [Iontophoresis in the conservative treatment of Peyronie's disease: preliminary experience].
    Treffiletti S; Annoscia S; Montefiore F; Boccafoschi C
    Arch Ital Urol Androl; 1997 Dec; 69(5):323-7. PubMed ID: 9477619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iontophoresis for treatment of Peyronie's disease.
    Riedl CR; Plas E; Engelhardt P; Daha K; Pflüger H
    J Urol; 2000 Jan; 163(1):95-9. PubMed ID: 10604323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal iontophoresis with verapamil and dexamethasone in the acute phase of peyronie's disease. Our experience.
    Garrido Abad P; Coloma A; Herranz LM; Jiménez M; Suárez C; Prieto MD; Formoso T; Fernández Arjona M
    Arch Esp Urol; 2012 Oct; 65(8):745-51. PubMed ID: 23117682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results.
    Montorsi F; Salonia A; Guazzoni G; Barbieri L; Colombo R; Brausi M; Scattoni V; Rigatti P; Pizzini G
    J Androl; 2000; 21(1):85-90. PubMed ID: 10670523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transdermal iontophoresis with dexamethasone and verapamil for Peyronie's disease].
    Cabello Benavente R; Moncada Iribarren I; de Palacio España A; Hernández Villaverde A; Monzó JI; Hernández Fernández C
    Actas Urol Esp; 2005; 29(10):955-60. PubMed ID: 16447593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
    Greenfield JM; Shah SJ; Levine LA
    J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
    Di Stasi SM; Giannantoni A; Capelli G; Jannini EA; Virgili G; Storti L; Vespasiani G
    BJU Int; 2003 Jun; 91(9):825-9. PubMed ID: 12780842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
    Di Stasi SM; Giannantoni A; Stephen RL; Capelli G; Giurioli A; Jannini EA; Vespasiani G
    J Urol; 2004 Apr; 171(4):1605-8. PubMed ID: 15017231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
    Cavallini G; Modenini F; Vitali G
    Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.
    Alizadeh M; Karimi F; Fallah MR
    Glob J Health Sci; 2014 Sep; 6(7 Spec No):23-30. PubMed ID: 25363175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease.
    Mehrsai AR; Namdari F; Salavati A; Dehghani S; Allameh F; Pourmand G
    Andrology; 2013 Jan; 1(1):129-32. PubMed ID: 23258641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
    Rehman J; Benet A; Melman A
    Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
    Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
    Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.
    Fitch WP; Easterling WJ; Talbert RL; Bordovsky MJ; Mosier M
    J Sex Med; 2007 Mar; 4(2):477-84. PubMed ID: 17367443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional verapamil prevents the progression of Peyronie's disease.
    Bennett NE; Guhring P; Mulhall JP
    Urology; 2007 Jun; 69(6):1181-4. PubMed ID: 17572211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease.
    Tuygun C; Ozok UH; Gucuk A; Bozkurt IH; Imamoglu MA
    Int Urol Nephrol; 2009; 41(1):113-8. PubMed ID: 18592390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic corticosteroid treatment in Peyronie's disease.
    Uzun H
    Med Hypotheses; 2013 Dec; 81(6):1029-30. PubMed ID: 24119766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Peyronie's disease with intralesional verapamil injection.
    Levine LA
    J Urol; 1997 Oct; 158(4):1395-9. PubMed ID: 9302129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iontophoresis in Peyronie's disease. Our experience].
    Pérez Espejo Mde L; Campoy Martínez P; Pérez Pérez M; Argüelles Salido E; Rodríguez Pérez A; Soltero González A
    Arch Esp Urol; 2003 Dec; 56(10):1133-7. PubMed ID: 14763419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.